Bicara Therapeutics Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -26,622 | -20,613 |
EBIT | -26,637 | -20,628 |
Net Income | -20,957 | -17,481 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -30,072 | -17,232 |
Cash | 489,711 | 520,758 |
Basic Shares | 111,232 | 54,409 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -82,389 | -51,961 | -37,722 |
EBIT | -51,980 | -37,732 | |
Net Income | -67,995 | -51,985 | -37,845 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -74,822 | -46,214 | -32,268 |
Cash | 489,711 | 230,440 | 4,158 |
Basic Shares | 168,055 | 51,760 | 51,760 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.38 |
2024-09-30 | -$0.32 |
